- Home
- IRWD vs NMAI Comparison
IRWD vs NMAI Comparison
Compare IRWD & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- NMAI
- Stock Information
- Founded
- IRWD 1998
- NMAI 2021
- Country
- IRWD United States
- NMAI United States
- Employees
- IRWD N/A
- NMAI N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- NMAI Investment Managers
- Sector
- IRWD Health Care
- NMAI Finance
- Exchange
- IRWD Nasdaq
- NMAI Nasdaq
- Market Cap
- IRWD 510.5M
- NMAI 430.5M
- IPO Year
- IRWD 2010
- NMAI N/A
- Fundamental
- Price
- IRWD $3.53
- NMAI $12.19
- Analyst Decision
- IRWD Buy
- NMAI
- Analyst Count
- IRWD 4
- NMAI 0
- Target Price
- IRWD $12.00
- NMAI N/A
- AVG Volume (30 Days)
- IRWD 1.9M
- NMAI 74.8K
- Earning Date
- IRWD 02-13-2025
- NMAI 01-01-0001
- Dividend Yield
- IRWD N/A
- NMAI 13.14%
- EPS Growth
- IRWD N/A
- NMAI N/A
- EPS
- IRWD N/A
- NMAI 0.64
- Revenue
- IRWD $378,418,000.00
- NMAI N/A
- Revenue This Year
- IRWD N/A
- NMAI N/A
- Revenue Next Year
- IRWD N/A
- NMAI N/A
- P/E Ratio
- IRWD N/A
- NMAI $19.03
- Revenue Growth
- IRWD N/A
- NMAI N/A
- 52 Week Low
- IRWD $3.06
- NMAI $10.60
- 52 Week High
- IRWD $15.70
- NMAI $12.55
- Technical
- Relative Strength Index (RSI)
- IRWD 44.66
- NMAI 27.78
- Support Level
- IRWD $3.39
- NMAI $12.79
- Resistance Level
- IRWD $4.05
- NMAI $12.89
- Average True Range (ATR)
- IRWD 0.30
- NMAI 0.09
- MACD
- IRWD 0.02
- NMAI -0.06
- Stochastic Oscillator
- IRWD 47.47
- NMAI 1.25
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment strategy uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.